Announcements Trials

Browse Landscape

Phase

Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 28 Neoplasms 11 Neoplasm Metastasis 5 Colorectal Neoplasms 3 Thyroid Neoplasms 2 Skin Neoplasms 2 Thyroid cancer, follicular 1 Thyroid Cancer, Papillary 1 Thrombocytosis 1 Solid Tumor 1 Recurrence 1 Prostatic Neoplasms 1 Primary Myelofibrosis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pancreatic Neoplasms 1 Noonan syndrome 3 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Lymphoma 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1 Leukemia, Myeloid, Acute 1 Leukemia, Myeloid, Accelerated Phase 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Hodgkin Disease 1

Interventions

Rituximab 57 Cyclophosphamide 56 fludarabine 37 fludarabine phosphate 31 Filgrastim 27 Etoposide 22 Bortezomib 20 Melphalan 19 Gemcitabine 19 Cytarabine 17 Bendamustine Hydrochloride 17 Peripheral Blood Stem Cell Transplantation 16 Vincristine 15 pembrolizumab 14 aldesleukin 13 Prednisone 13 Doxorubicin 12 Dexamethasone 12 Busulfan 12 Whole-Body Irradiation 11 Vorinostat 11 Tacrolimus 11 Sirolimus 11 sargramostim 10 obinutuzumab 10 Lenalidomide 10 romidepsin 9 Radiotherapy 9 Rifampin 8 Paclitaxel 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Lymphoma × Vemurafenib × Clear all

NCT01636622 2020-06-18

Study of Vemurafenib, Carboplatin, and Paclitaxel

M.D. Anderson Cancer Center

Phase 1 Completed

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡